Global survey explores whether maintenance HER2-targeted therapy can be stopped after prolonged remission in HER2-positive ...
Short-Course Radiotherapy Supports Organ Preservation in Locally Advanced Rectal Cancer / locally advanced rectal cancer, ...
A new PET imaging approach detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), potentially giving ...
Objectives Tuberculosis (TB) in the USA disproportionately affects non-US-born individuals. While testing this population for ...
Femasys is a commercial-stage medtech company targeting OB/GYNs with in-office fertility and permanent birth control ...
GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as ...
Patient’s Skin Improved from Severe to Clear with Complete Elimination of Pruritus (itch) – After 21 Months of Treatment with ...
The US Food and Drug Administration (FDA) has approved pritelivir (HOVILPRI; Asahi Kasei Therapeutics) 100-mg tablets for the ...
In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 monotherapy at Week 12, the primary ...
If approved, TALVEY® plus daratumumab will be the only GPRC5D-targeting bispecific antibody combination therapy for relapsed or refractory multiple myeloma as early as second lineCHMP recommendation ...
On October 15, 2026, the Ministry of Health, Labour and Welfare's Pharmaceutical Affairs and Food Sanitation Council's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results